Structural basis for HIV-1 Gag interactions with cellular constituents
HIV-1 Gag 与细胞成分相互作用的结构基础
基本信息
- 批准号:8011917
- 负责人:
- 金额:$ 36.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-05-15 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAntiviral AgentsBindingBiochemicalBiological AssayCalciumCalmodulinCell membraneCell physiologyCellsComplexCytokine Inducible SH2-Containing ProteinCytoplasmDataDevelopmentDrug DesignElectrostaticsGaggingHIVHIV InfectionsHIV-1HistidineHumanInfectionIntegration Host FactorsKnowledgeLeadLecithinLifeLipidsLocationMembraneMembrane LipidsMethodsMicellesModelingMolecularMutagenesisNuclear Magnetic ResonanceNucleocapsidPathway interactionsPeptidesPhasePhosphatidylethanolaminePhosphatidylinositol 4,5-DiphosphatePhosphatidylinositolsPhosphatidylserinesPhospholipidsPropertyProtein BindingProteinsPublic HealthResearchResolutionRoleSafetySignal PathwaySignal TransductionSpecificityStagingStructureTechniquesTherapeutic AgentsVirus Replicationbasedesigngag Gene Productsin vivomembrane assemblymembrane modelnovel strategiesparticlepathogenphosphatidylethanolamineprotein complexpublic health relevancestructural biologythree dimensional structuretooltrafficking
项目摘要
DESCRIPTION (provided by applicant): Within cells proteins are targeted to well-defined locations by specific interactions with cellular constituents such as proteins and phospholipids. During the late phase of HIV-1 infection, Gag polyproteins are transported to the plasma membrane (PM) for assembly. Using nuclear magnetic resonance (NMR) we have previously defined the molecular basis of one component of Gag targeting to the PM, the interaction of the matrix (MA) domain with phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2). Our preliminary data indicate that Gag also forms biologically important interactions with cellular lipids and proteins implicated in efficient particle assembly. We show that MA interacts directly with phosphatidylserine (PtdSer), phosphatidylcholine (PtdCho) and phosphatidylethanolamine (PtdEtn), suggesting that Gag targeting and assembly on the PM proceed via a dual engagement of the MA domain with PI(4,5)P2 and major membrane lipids. A number of cellular proteins have been proposed to facilitate Gag intracellular trafficking and targeting to the PM. HIV-1 Gag was shown to interact and co-localize with calmodulin (CaM) in the cytoplasm. In addition, more recent studies have identified the suppressor of cytokine signaling 1 (SOCS1) as an inducible host factor during HIV infection, which regulates the late stages of the virus replication pathway through direct interactions with the Gag protein. However, the molecular mechanism by which Gag interacts with these factors has yet to be established. Preliminary studies demonstrate that HIV-1 MA interacts directly with CaM in a calcium- dependent manner, suggesting that HIV-1 hijacks CaM cell-signaling pathway to facilitate Gag trafficking. In addition, we have obtained evidence for direct interactions between SOCS1 and the MA protein. In this proposal, we will employ biochemical, biophysical and structural biology tools to identify key protein-protein and protein-lipid interactions involved in the molecular mechanism governing HIV-1 Gag intracellular trafficking and assembly. Our three main aims are: (i) to determine the precise molecular mechanism for Gag binding to the PM. We will determine at the structural level how various lipid constituents interact with the MA protein and will identify the functional importance of the hydrophobic insertion, specific and non- specific electrostatic interactions, (ii) to identify the functional role of CaM in Gag trafficking and assembly, and (iii) to elucidate the structural requirements for SOCS1-Gag interactions. The results generated by this research will offer a better understanding of how HIV-1 Gag interacts with cellular constituents at the atomic level, which could lead to new approaches to rational design of new antiviral therapeutic agents that inhibit Gag trafficking and assembly.
PUBLIC HEALTH RELEVANCE: HIV remains the most deadly pathogen that threatens human's life and the lack of efficient cure poses a major problem in public health and safety. Major efforts are now being focused on understanding how HIV interacts with the host cell during the replication cycle. The proposed studies will help in understanding the precise molecular mechanism of HIV Gag trafficking and assembly, which may aid in the development of new strategies for antiviral drug design.
描述(由申请方提供):在细胞内,蛋白质通过与细胞成分(如蛋白质和磷脂)的特异性相互作用靶向明确的位置。在HIV-1感染的晚期,Gag多聚蛋白被转运到质膜(PM)进行组装。使用核磁共振(NMR),我们先前已经定义了靶向PM的Gag的一个组分的分子基础,即基质(MA)结构域与磷脂酰肌醇-4,5-二磷酸(PI(4,5)P2)的相互作用。我们的初步数据表明,Gag还与涉及有效颗粒组装的细胞脂质和蛋白质形成生物学上重要的相互作用。我们发现MA直接与磷脂酰丝氨酸(PtdSer),磷脂酰胆碱(PtdCho)和磷脂酰乙醇胺(PtdEtn)相互作用,表明Gag靶向和PM上的组装通过MA结构域与PI(4,5)P2和主要膜脂质的双重参与进行。已经提出了许多细胞蛋白以促进Gag细胞内运输和靶向PM。HIV-1 Gag与钙调蛋白(CaM)在细胞质中相互作用并共定位。此外,最近的研究已经将细胞因子信号转导抑制因子1(SOCS 1)鉴定为HIV感染期间的诱导性宿主因子,其通过与Gag蛋白的直接相互作用来调节病毒复制途径的晚期阶段。然而,Gag与这些因子相互作用的分子机制尚未建立。初步研究表明,HIV-1 MA以钙依赖性方式与CaM直接相互作用,表明HIV-1劫持CaM细胞信号传导途径以促进Gag运输。此外,我们已经获得了SOCS 1和MA蛋白之间直接相互作用的证据。在这项提案中,我们将采用生物化学,生物物理学和结构生物学工具,以确定关键的蛋白质-蛋白质和蛋白质-脂质相互作用参与的分子机制,管理HIV-1 Gag细胞内运输和组装。我们的三个主要目标是:(i)确定Gag与PM结合的精确分子机制。我们将在结构水平上确定各种脂质成分如何与MA蛋白相互作用,并将确定疏水插入,特异性和非特异性静电相互作用的功能重要性,(ii)确定CaM在Gag运输和组装中的功能作用,以及(iii)阐明SOCS 1-Gag相互作用的结构要求。这项研究产生的结果将更好地了解HIV-1 Gag如何在原子水平上与细胞成分相互作用,这可能导致合理设计抑制Gag运输和组装的新型抗病毒治疗剂的新方法。
公共卫生关系:艾滋病毒仍然是威胁人类生命的最致命的病原体,缺乏有效的治疗方法是公共卫生和安全的主要问题。目前的主要努力集中在了解艾滋病毒在复制周期中如何与宿主细胞相互作用。拟议的研究将有助于理解HIV Gag运输和组装的精确分子机制,这可能有助于开发抗病毒药物设计的新策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jamil Subhi Saad其他文献
Jamil Subhi Saad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jamil Subhi Saad', 18)}}的其他基金
Structural basis for cellular secretion and uptake of HIV-1 Tat
HIV-1 Tat 细胞分泌和摄取的结构基础
- 批准号:
9926634 - 财政年份:2020
- 资助金额:
$ 36.63万 - 项目类别:
Structural basis for HIV-1 Gag interactions with cellular constituents
HIV-1 Gag 与细胞成分相互作用的结构基础
- 批准号:
8457022 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural basis for HIV-1 Gag interactions with cellular and viral constituents
HIV-1 Gag 与细胞和病毒成分相互作用的结构基础
- 批准号:
10226955 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural basis for HIV-1 Gag interactions with cellular and viral constituents
HIV-1 Gag 与细胞和病毒成分相互作用的结构基础
- 批准号:
9979755 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural Basis for HIV-1 Gag Interactions with Cellular Constituents
HIV-1 Gag 与细胞成分相互作用的结构基础
- 批准号:
9147626 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural basis for HIV-1 Gag interactions with cellular constituents
HIV-1 Gag 与细胞成分相互作用的结构基础
- 批准号:
8638883 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural Basis for HIV-1 Gag Interactions with Cellular Constituents
HIV-1 Gag 与细胞成分相互作用的结构基础
- 批准号:
9340233 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural basis for HIV-1 Gag interactions with cellular constituents
HIV-1 Gag 与细胞成分相互作用的结构基础
- 批准号:
8073053 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural Basis for HIV-1 Gag Interactions with Cellular Constituents
HIV-1 Gag 与细胞成分相互作用的结构基础
- 批准号:
9304625 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
Structural basis for HIV-1 Gag interactions with cellular and viral constituents
HIV-1 Gag 与细胞和病毒成分相互作用的结构基础
- 批准号:
10462579 - 财政年份:2010
- 资助金额:
$ 36.63万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 36.63万 - 项目类别:
Continuing Grant